Accelerate Diagnostics (Accelerate Diagnostics) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Accelerate Diagnostics 3-Year Dividend Growth Rate?

Accelerate Diagnostics's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The historical rank and industry rank for Accelerate Diagnostics's 3-Year Dividend Growth Rate or its related term are showing as below:

AXDX's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 11.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Accelerate Diagnostics's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Accelerate Diagnostics's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Accelerate Diagnostics's 3-Year Dividend Growth Rate

For the Medical Devices subindustry, Accelerate Diagnostics's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's 3-Year Dividend Growth Rate falls into.

Accelerate Diagnostics 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Accelerate Diagnostics (NAS:AXDX) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Accelerate Diagnostics's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-0.678
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerate Diagnostics 3-Year Dividend Growth Rate Related Terms>

Accelerate Diagnostics (Accelerate Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (NAS:AXDX) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

AXDX:Mexico 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Executives

David Patience	officer: Chief Financial Officer	C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 240, TUCSON AZ 85714
Jack Phillips	director, officer: PRESIDENT AND CEO	11731 YALE DR, CARMEL IN 46032
Larry Michael Mertz	officer: Chief Technology Officer	3950 S. COUNTRY CLUB ROAD, TUCSON AZ 85714
Marran H. Ogilvie	director	599 LEXINGTON AVENUE, NEW YORK NY 10022
Jennifer Regan	director	C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Mark S. Black	director	3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Steven Reichling	officer: CFO	7000 NORTH BROADWAY, BUILDING 3-307, DENVER CO 80221
Ron Price	officer: SVP & HEAD OF COM OPS AMERICAS	3950 SOUTH COUNTRY CLUB ROAD, SUITE 470, TUCSON AZ 85714
Wayne Burris	director	3451 PLANO PARKWAY, LEWISVILLE TX 75056
Hany Massarany	director	1910 INNOVATION PARK DR, TUCSON AZ 85737
Jack W Schuler	director, 10 percent owner	100 N. FIELD DRIVE, SUITE 360, LAKE FOREST IL 60045
Mark C Miller	director	C/O STERICYCLE INC., 28161 N KEITH DRIVE, LAKE FOREST IL 60045
Ten Brink Frank Jm	director	C/O STERICYCLE INC, 28161 N KEITH DR, LAKE FOREST IL 60045
Charles M Watts	director	3950 SOUTH COUNTRY CLUB, SUITE 470, TUCSON AZ 85714
Louise Francesconi	director	870 WINTER STREET, WALTHAM MA 02451